1. Home
  2. VSAT vs ELVN Comparison

VSAT vs ELVN Comparison

Compare VSAT & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSAT
  • ELVN
  • Stock Information
  • Founded
  • VSAT 1986
  • ELVN 2016
  • Country
  • VSAT United States
  • ELVN United States
  • Employees
  • VSAT N/A
  • ELVN N/A
  • Industry
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSAT Technology
  • ELVN Health Care
  • Exchange
  • VSAT Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • VSAT 1.1B
  • ELVN 1.1B
  • IPO Year
  • VSAT 1996
  • ELVN 2020
  • Fundamental
  • Price
  • VSAT $8.49
  • ELVN $16.53
  • Analyst Decision
  • VSAT Buy
  • ELVN Strong Buy
  • Analyst Count
  • VSAT 7
  • ELVN 4
  • Target Price
  • VSAT $17.14
  • ELVN $39.25
  • AVG Volume (30 Days)
  • VSAT 2.8M
  • ELVN 359.8K
  • Earning Date
  • VSAT 05-20-2025
  • ELVN 05-13-2025
  • Dividend Yield
  • VSAT N/A
  • ELVN N/A
  • EPS Growth
  • VSAT N/A
  • ELVN N/A
  • EPS
  • VSAT N/A
  • ELVN N/A
  • Revenue
  • VSAT $4,522,502,000.00
  • ELVN N/A
  • Revenue This Year
  • VSAT $7.52
  • ELVN N/A
  • Revenue Next Year
  • VSAT $2.15
  • ELVN N/A
  • P/E Ratio
  • VSAT N/A
  • ELVN N/A
  • Revenue Growth
  • VSAT 19.02
  • ELVN N/A
  • 52 Week Low
  • VSAT $6.69
  • ELVN $13.30
  • 52 Week High
  • VSAT $26.70
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • VSAT 43.53
  • ELVN 40.34
  • Support Level
  • VSAT $8.06
  • ELVN $15.49
  • Resistance Level
  • VSAT $8.85
  • ELVN $18.14
  • Average True Range (ATR)
  • VSAT 0.82
  • ELVN 1.93
  • MACD
  • VSAT -0.13
  • ELVN -0.17
  • Stochastic Oscillator
  • VSAT 34.35
  • ELVN 41.09

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: